Applied Therapeutics, Inc.

NasdaqGM:APLT Stock Report

Market Cap: US$484.4m

Applied Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:APLT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
14 Mar 24SellUS$1,717,108Shoshana ShendelmanIndividual318,573US$5.39
14 Mar 24SellUS$263,415Adam HansardIndividual48,871US$5.39
14 Mar 24SellUS$154,839Les FuntleyderIndividual28,727US$5.39
14 Mar 24SellUS$597,234Riccardo PerfettiIndividual110,804US$5.39
01 Dec 23BuyUS$65,367Stacy KanterIndividual30,000US$2.18
30 Nov 23SellUS$1,901Adam HansardIndividual965US$1.97
30 Nov 23SellUS$7,817Shoshana ShendelmanIndividual3,968US$1.97
30 Nov 23SellUS$3,119Riccardo PerfettiIndividual1,583US$1.97
03 Nov 23SellUS$572,204Alexandria Venture Investments, LLCCompany247,258US$2.32
01 Nov 23SellUS$781,221Alexandria Venture Investments, LLCCompany327,742US$2.41
27 Sep 23SellUS$26,244Adam HansardIndividual9,720US$2.70
27 Sep 23SellUS$29,516Riccardo PerfettiIndividual10,932US$2.70
27 Sep 23SellUS$312,206Shoshana ShendelmanIndividual115,632US$2.70

Insider Trading Volume

Insider Buying: APLT insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of APLT?
Owner TypeNumber of SharesOwnership Percentage
Private Companies3,340,7522.92%
Individual Insiders3,737,0283.27%
General Public6,373,0435.58%
VC/PE Firms23,235,07720.3%
Institutions77,555,90367.9%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 97.5%.


Top Shareholders

Top 25 shareholders own 81.29% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.25%
Franklin Resources, Inc.
10,564,345US$44.8m50.5%0.02%
7.94%
VR Adviser, LLC
9,075,000US$38.5m45.2%1.67%
7.01%
Perceptive Advisors LLC
8,005,000US$33.9m96.2%0.65%
5.61%
Janus Henderson Group plc
6,414,642US$27.2m199%0.01%
5.39%
Alexandria Venture Investments, LLC
6,155,077US$26.1m0%100.0%
5.35%
Propel Bio Management, LLC
6,111,906US$25.9m13.7%16.95%
4.88%
Knoll Capital Management
5,574,687US$23.6m1.83%19.49%
4.47%
Vestal Point Capital, LP
5,110,000US$21.7m23%1.88%
2.84%
Sycamore Family LLC
3,242,094US$13.7m0%no data
2.8%
Morgan Stanley, Investment Banking and Brokerage Investments
3,194,052US$13.5m5,860%no data
2.64%
The Vanguard Group, Inc.
3,010,290US$12.8m-6.82%no data
2.47%
Simplify Asset Management Inc.
2,817,505US$11.9m16.6%1.09%
2.32%
Adage Capital Management, L.P.
2,649,784US$11.2m0%0.02%
1.95%
Tang Capital Management, LLC
2,230,000US$9.5m0%1.04%
1.77%
StemPoint Capital LP
2,017,016US$8.6m122%2.51%
1.71%
Frazier Life Sciences Management, LP
1,952,857US$8.3m0%0.33%
1.71%
Shoshana Shendelman
1,950,152US$8.3m-62.3%no data
1.62%
Parkman Healthcare Partners LLC
1,854,763US$7.9m82%1.0%
1.61%
Schonfeld Strategic Advisors LLC
1,836,642US$7.8m274%0.06%
1.55%
Opaleye Management Inc.
1,770,000US$7.5m62%1.81%
1.37%
Soleus Capital Management, L.P.
1,564,916US$6.6m240%0.62%
1.31%
Rock Springs Capital Management LP
1,497,918US$6.4m67.3%0.17%
1.3%
Laurion Capital Management LP
1,481,006US$6.3m244%0.18%
1.26%
Alyeska Investment Group, L.P.
1,442,926US$6.1m-44.6%0.04%
1.18%
Logos Global Management, L.P.
1,350,000US$5.7m-18.7%0.67%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.